{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T09:22:06Z","timestamp":1787908926358,"version":"build-2784847793"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Joint Program on Health Science & Technology Innovation of Hainan Province","award":["WSJK2026QN075"],"award-info":[{"award-number":["WSJK2026QN075"]}]},{"name":"Joint Program on Health Science & Technology Innovation of Hainan Province","award":["WSJK2026QN075"],"award-info":[{"award-number":["WSJK2026QN075"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"DOI":"10.1007\/s11010-026-05624-9","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T15:54:41Z","timestamp":1782921281000},"page":"3747-3759","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ellagic acid from the traditional Chinese medicinal herb Scutellaria barbata may accelerates apoptosis in hepatic stellate cells during liver fibrosis via inhibiting miR-182-5p"],"prefix":"10.1007","volume":"481","author":[{"given":"Feng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhehao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinqiang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxiu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"key":"5624_CR1","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/j.cmet.2024.05.003","volume":"36","author":"P Horn","year":"2024","unstructured":"Horn P, Tacke F (2024) Metabolic reprogramming in liver fibrosis. Cell Metab 36:1439\u20131455. https:\/\/doi.org\/10.1016\/j.cmet.2024.05.003","journal-title":"Cell Metab"},{"key":"5624_CR2","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.jcmgh.2023.05.010","volume":"16","author":"YS Lee","year":"2023","unstructured":"Lee YS, Seki E (2023) In vivo and in vitro models to study liver fibrosis: mechanisms and limitations. Cell Mol Gastroenterol Hepatol 16:355\u2013367. https:\/\/doi.org\/10.1016\/j.jcmgh.2023.05.010","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"5624_CR3","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","volume":"14","author":"T Tsuchida","year":"2017","unstructured":"Tsuchida T, Friedman SL (2017) Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol 14:397\u2013411. https:\/\/doi.org\/10.1038\/nrgastro.2017.38","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"5624_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202404089","volume":"12","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Li X, Chen H, Li J, Guo X, Fang Y, Chen L, Li K, Zhang Y, Kong F, Chen A, Lyu J, Zhang W, Wang Z (2025) Cancer cell-derived exosomal miR-500a-3p modulates hepatic stellate cell activation and the immunosuppressive microenvironment. Adv Sci (Weinh) 12:e2404089. https:\/\/doi.org\/10.1002\/advs.202404089","journal-title":"Adv Sci (Weinh)"},{"key":"5624_CR5","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.semcdb.2015.02.008","volume":"40","author":"DW Greening","year":"2015","unstructured":"Greening DW, Gopal SK, Mathias RA, Liu L, Sheng J, Zhu HJ, Simpson RJ (2015) Emerging roles of exosomes during epithelial-mesenchymal transition and cancer progression. Semin Cell Dev Biol 40:60\u201371. https:\/\/doi.org\/10.1016\/j.semcdb.2015.02.008","journal-title":"Semin Cell Dev Biol"},{"key":"5624_CR6","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/hep.30607","volume":"70","author":"J Liu","year":"2019","unstructured":"Liu J, Fan L, Yu H, Zhang J, He Y, Feng D, Wang F, Li X, Liu Q, Li Y, Guo Z, Gao B, Wei W, Wang H, Sun G (2019) Endoplasmic reticulum stress causes liver cancer cells to release exosomal miR-23a-3p and up-regulate programmed death ligand 1 expression in macrophages. Hepatology 70:241\u2013258. https:\/\/doi.org\/10.1002\/hep.30607","journal-title":"Hepatology"},{"key":"5624_CR7","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/s41392-020-00359-5","volume":"5","author":"E Yang","year":"2020","unstructured":"Yang E, Wang X, Gong Z, Yu M, Wu H, Zhang D (2020) Exosome-mediated metabolic reprogramming: the emerging role in tumor microenvironment remodeling and its influence on cancer progression. Signal Transduct Target Ther 5:242. https:\/\/doi.org\/10.1038\/s41392-020-00359-5","journal-title":"Signal Transduct Target Ther"},{"key":"5624_CR8","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s40265-024-02045-0","volume":"84","author":"SJ Keam","year":"2024","unstructured":"Keam SJ (2024) Resmetirom: first approval. Drugs 84:729\u2013735. https:\/\/doi.org\/10.1007\/s40265-024-02045-0","journal-title":"Drugs"},{"key":"5624_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2019.112442","volume":"251","author":"H Li","year":"2020","unstructured":"Li H (2020) Advances in anti hepatic fibrotic therapy with traditional Chinese medicine herbal formula. J Ethnopharmacol 251:112442. https:\/\/doi.org\/10.1016\/j.jep.2019.112442","journal-title":"J Ethnopharmacol"},{"key":"5624_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2019.112260","volume":"254","author":"L Wang","year":"2020","unstructured":"Wang L, Chen W, Li M, Zhang F, Chen K, Chen W (2020) A review of the ethnopharmacology, phytochemistry, pharmacology, and quality control of Scutellaria barbata D. Don. J Ethnopharmacol 254:112260. https:\/\/doi.org\/10.1016\/j.jep.2019.112260","journal-title":"J Ethnopharmacol"},{"key":"5624_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2021.114110","volume":"275","author":"PW Yang","year":"2021","unstructured":"Yang PW, Chen TT, Zhao WX, Liu GW, Feng XJ, Wang SM, Pan YC, Wang Q, Zhang SH (2021) Scutellaria barbata D.Don and Oldenlandia diffusa (Willd.) Roxb crude extracts inhibit hepatitis-B-virus-associated hepatocellular carcinoma growth through regulating circRNA expression. J Ethnopharmacol 275:114110. https:\/\/doi.org\/10.1016\/j.jep.2021.114110","journal-title":"J Ethnopharmacol"},{"key":"5624_CR12","doi-asserted-by":"publisher","first-page":"80","DOI":"10.12122\/j.issn.1673-4254.2025.01.11","volume":"45","author":"M Xu","year":"2025","unstructured":"Xu M, Chen L, Wu J, Liu L, Shi M, Zhou H, Zhang G (2025) Mechanism of Hedyotis diffusa-Scutellaria barbata D. Don for treatment of primary liver cancer: analysis with network pharmacology, molecular docking and in vitro validation. Nan Fang Yi Ke Da Xue Xue Bao 45:80\u201389. https:\/\/doi.org\/10.12122\/j.issn.1673-4254.2025.01.11","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"5624_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijbiomac.2022.02.119","volume":"206","author":"X Wu","year":"2022","unstructured":"Wu X, Xu N, Ye Z, Zhao Q, Liu J, Li J, Wu M, Zheng Y, Li X, Li W, Zhang T, Hu X, Zhang Q (2022) Polysaccharide from Scutellaria barbata D. Don attenuates inflammatory response and microbial dysbiosis in ulcerative colitis mice. Int J Biol Macromol 206:1\u20139. https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.02.119","journal-title":"Int J Biol Macromol"},{"key":"5624_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2025.119653","volume":"346","author":"YC Chen","year":"2025","unstructured":"Chen YC, Lee YR, Chang YC, Wang YH, Fang SY, Lin CH, Chen PJ, Hwang TL (2025) Scutellaria barbata ameliorates acute respiratory distress syndrome by inhibiting neutrophil-mediated inflammatory responses. J Ethnopharmacol 346:119653. https:\/\/doi.org\/10.1016\/j.jep.2025.119653","journal-title":"J Ethnopharmacol"},{"key":"5624_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-024-01570-6","volume":"17","author":"X Sui","year":"2024","unstructured":"Sui X, Gao B, Zhang L, Wang Y, Ma J, Wu X, Zhou C, Liu M, Zhang L (2024) Scutellaria barbata D.Don and Hedyotis diffusa Willd herb pair combined with cisplatin synergistically inhibits ovarian cancer progression through modulating oxidative stress via NRF2-FTH1 autophagic degradation pathway. J Ovarian Res 17:246. https:\/\/doi.org\/10.1186\/s13048-024-01570-6","journal-title":"J Ovarian Res"},{"key":"5624_CR16","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.lfs.2016.01.018","volume":"157","author":"Z Wang","year":"2016","unstructured":"Wang Z, Yu J, Wu J, Qi F, Wang H, Wang Z, Xu Z (2016) Scutellarin protects cardiomyocyte ischemia-reperfusion injury by reducing apoptosis and oxidative stress. Life Sci 157:200\u2013207. https:\/\/doi.org\/10.1016\/j.lfs.2016.01.018","journal-title":"Life Sci"},{"key":"5624_CR17","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.jep.2016.02.012","volume":"182","author":"G Tao","year":"2016","unstructured":"Tao G, Balunas MJ (2016) Current therapeutic role and medicinal potential of Scutellaria barbata in Traditional Chinese Medicine and Western research. J Ethnopharmacol 182:170\u2013180. https:\/\/doi.org\/10.1016\/j.jep.2016.02.012","journal-title":"J Ethnopharmacol"},{"key":"5624_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2020.113198","volume":"265","author":"J Shen","year":"2021","unstructured":"Shen J, Li P, Liu S, Liu Q, Li Y, Sun Y, He C, Xiao P (2021) Traditional uses, ten-years research progress on phytochemistry and pharmacology, and clinical studies of the genus Scutellaria. J Ethnopharmacol 265:113198. https:\/\/doi.org\/10.1016\/j.jep.2020.113198","journal-title":"J Ethnopharmacol"},{"key":"5624_CR19","doi-asserted-by":"publisher","first-page":"4021","DOI":"10.1007\/s10238-023-01122-0","volume":"23","author":"F Li","year":"2023","unstructured":"Li F, Yan T, Wang S, Wen X (2023) Exosome-associated miRNA-99a-5p targeting BMPR2 promotes hepatocyte apoptosis during the process of hepatic fibrosis. Clin Exp Med 23:4021\u20134031. https:\/\/doi.org\/10.1007\/s10238-023-01122-0","journal-title":"Clin Exp Med"},{"key":"5624_CR20","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s10616-025-00738-2","volume":"77","author":"F Li","year":"2025","unstructured":"Li F, Wang B, Fu X, Liang J, Xiao X, Wei X (2025) Protective effects of Scutellaria barbata against hepatocyte apoptosis during hepatic fibrosis progression. Cytotechnology 77:78. https:\/\/doi.org\/10.1007\/s10616-025-00738-2","journal-title":"Cytotechnology"},{"key":"5624_CR21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jphs.2020.01.007","volume":"143","author":"NF Abdelkader","year":"2020","unstructured":"Abdelkader NF, Elyamany M, Gad AM, Assaf N, Fawzy HM, Elesawy WH (2020) Ellagic acid attenuates liver toxicity induced by valproic acid in rats. J Pharmacol Sci 143:23\u201329. https:\/\/doi.org\/10.1016\/j.jphs.2020.01.007","journal-title":"J Pharmacol Sci"},{"key":"5624_CR22","doi-asserted-by":"publisher","first-page":"156064","DOI":"10.1016\/j.phymed.2024.156064","volume":"135","author":"K Wang","year":"2024","unstructured":"Wang K, Hao Z, Xie J, Ma L, Zhang W, Mo J, Li L, Jin C (2024) Nrf2-dependent hepatoprotective effect of ellagic acid in titanium dioxide nanoparticles-induced liver injury. Phytomedicine 135:156064. https:\/\/doi.org\/10.1016\/j.phymed.2024.156064","journal-title":"Phytomedicine"},{"key":"5624_CR23","doi-asserted-by":"publisher","first-page":"e014571","DOI":"10.1136\/bmjopen-2016-014571","volume":"7","author":"TY Tsai","year":"2017","unstructured":"Tsai TY, Livneh H, Hung TH, Lin IH, Lu MC, Yeh CC (2017) Associations between prescribed Chinese herbal medicine and risk of hepatocellular carcinoma in patients with chronic hepatitis B: a nationwide population-based cohort study. BMJ Open 7:e014571. https:\/\/doi.org\/10.1136\/bmjopen-2016-014571","journal-title":"BMJ Open"},{"key":"5624_CR24","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/s0254-6272(08)60048-5","volume":"28","author":"Z Dai","year":"2008","unstructured":"Dai Z, Liu X, Ji Z, Liu L, Kang H, Wang X, Diao Y (2008) The effect-enhancing and toxicity-reducing action of the extract of herba Scutellariae barbatae for chemotherapy in hepatoma H22 tumor-bearing mice. J Tradit Chin Med 28:205\u2013210. https:\/\/doi.org\/10.1016\/s0254-6272(08)60048-5","journal-title":"J Tradit Chin Med"},{"key":"5624_CR25","doi-asserted-by":"publisher","first-page":"261","DOI":"10.7314\/apjcp.2013.14.1.261","volume":"14","author":"ZJ Dai","year":"2013","unstructured":"Dai ZJ, Wu WY, Kang HF, Ma XB, Zhang SQ, Min WL, Kang WF, Ma XB, Zhang SQ, Min WL, Lu WF, Lin S, Wang XJ (2013) Protective effects of Scutellaria barbata against rat liver tumorigenesis. Asian Pac J Cancer Prev 14:261\u2013265. https:\/\/doi.org\/10.7314\/apjcp.2013.14.1.261","journal-title":"Asian Pac J Cancer Prev"},{"key":"5624_CR26","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.4161\/cbt.5.9.2950","volume":"5","author":"PM Tang","year":"2006","unstructured":"Tang PM, Chan JY, Au SW, Kong SK, Tsui SK, Waye MM, Mak TC, Fong WP, Fung KP (2006) Pheophorbide a, an active compound isolated from Scutellaria barbata, possesses photodynamic activities by inducing apoptosis in human hepatocellular carcinoma. Cancer Biol Ther 5:1111\u20131116. https:\/\/doi.org\/10.4161\/cbt.5.9.2950","journal-title":"Cancer Biol Ther"},{"key":"5624_CR27","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1007\/s13277-013-1336-4","volume":"35","author":"J Gao","year":"2014","unstructured":"Gao J, Lu WF, Dai ZJ, Lin S, Zhao Y, Li S, Zhao NN, Wang XJ, Kang HF, Ma XB, Zhang WG (2014) Induction of apoptosis by total flavonoids from Scutellaria barbata D. Don in human hepatocarcinoma MHCC97-H cells via the mitochondrial pathway. Tumour Biol 35:2549\u20132559. https:\/\/doi.org\/10.1007\/s13277-013-1336-4","journal-title":"Tumour Biol"},{"key":"5624_CR28","doi-asserted-by":"publisher","first-page":"e22731","DOI":"10.1002\/jbt.22731","volume":"35","author":"PP Feng","year":"2021","unstructured":"Feng PP, Qi YK, Li N, Fei HR (2021) Scutebarbatine A induces cytotoxicity in hepatocellular carcinoma via activation of the MAPK and ER stress signaling pathways. J Biochem Mol Toxicol 35:e22731. https:\/\/doi.org\/10.1002\/jbt.22731","journal-title":"J Biochem Mol Toxicol"},{"key":"5624_CR29","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.ijbiomac.2019.03.053","volume":"131","author":"H Li","year":"2019","unstructured":"Li H, Su J, Jiang J, Li Y, Gan Z, Ding Y, Li Y, Liu J, Wang S, Ke Y (2019) Characterization of polysaccharide from Scutellaria barbata and its antagonistic effect on the migration and invasion of HT-29 colorectal cancer cells induced by TGF-\u03b21. Int J Biol Macromol 131:886\u2013895. https:\/\/doi.org\/10.1016\/j.ijbiomac.2019.03.053","journal-title":"Int J Biol Macromol"},{"key":"5624_CR30","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/j.1472-8206.2008.00618.x","volume":"22","author":"C Girish","year":"2008","unstructured":"Girish C, Pradhan SC (2008) Drug development for liver diseases: focus on picroliv, ellagic acid and curcumin. Fundam Clin Pharmacol 22:623\u2013632. https:\/\/doi.org\/10.1111\/j.1472-8206.2008.00618.x","journal-title":"Fundam Clin Pharmacol"},{"key":"5624_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/molecules30122596","author":"K Wojtunik-Kulesza","year":"2025","unstructured":"Wojtunik-Kulesza K, Nizi\u0144ski P, Krajewska A, Oniszczuk T, Combrzy\u0144ski M, Oniszczuk A (2025) Therapeutic potential of ellagic acid in liver diseases. Molecules. https:\/\/doi.org\/10.3390\/molecules30122596","journal-title":"Molecules"},{"key":"5624_CR32","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.phrs.2015.04.008","volume":"97","author":"WR Garc\u00eda-Ni\u00f1o","year":"2015","unstructured":"Garc\u00eda-Ni\u00f1o WR, Zazueta C (2015) Ellagic acid: pharmacological activities and molecular mechanisms involved in liver protection. Pharmacol Res 97:84\u2013103. https:\/\/doi.org\/10.1016\/j.phrs.2015.04.008","journal-title":"Pharmacol Res"},{"key":"5624_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10091386","author":"DH Kim","year":"2021","unstructured":"Kim DH, Sim Y, Hwang JH, Kwun IS, Lim JH, Kim J, Kim JI, Baek MC, Akbar M, Seo W, Kim DK, Song BJ, Cho YE (2021) Ellagic acid prevents binge alcohol-induced leaky gut and liver injury through inhibiting gut dysbiosis and oxidative stress. Antioxidants. https:\/\/doi.org\/10.3390\/antiox10091386","journal-title":"Antioxidants"},{"key":"5624_CR34","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1136\/gutjnl-2020-322526","volume":"70","author":"X Wang","year":"2021","unstructured":"Wang X, He Y, Mackowiak B, Gao B (2021) MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases. Gut 70:784\u2013795. https:\/\/doi.org\/10.1136\/gutjnl-2020-322526","journal-title":"Gut"},{"key":"5624_CR35","doi-asserted-by":"publisher","first-page":"73","DOI":"10.5114\/pg.2026.160545","volume":"21","author":"TI Ahmed","year":"2026","unstructured":"Ahmed TI, Mahmoud EA, Ismael NR, Abdelaleem OO, Hemeda NF, El-Dash HA, Abeer AK, Ali RA (2026) The potential role of serum miR-182-5p and miR-127-5p in diagnosis of metabolic dysfunction-associated steatotic liver disease and its relationship with insulin resistance. Prz Gastroenterol 21:73\u201381. https:\/\/doi.org\/10.5114\/pg.2026.160545","journal-title":"Prz Gastroenterol"},{"key":"5624_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-022-03714-0","volume":"5","author":"T Xiao","year":"2022","unstructured":"Xiao T, Meng W, Jin Z, Wang J, Deng J, Wen J, Liu B, Liu M, Bai J, Liu F (2022) MiR-182-5p promotes hepatocyte-stellate cell crosstalk to facilitate liver regeneration. Commun Biol 5:771. https:\/\/doi.org\/10.1038\/s42003-022-03714-0","journal-title":"Commun Biol"},{"key":"5624_CR37","doi-asserted-by":"publisher","first-page":"116","DOI":"10.5604\/01.3001.0012.7902","volume":"18","author":"Q Liang","year":"2019","unstructured":"Liang Q, Chen H, Xu X, Jiang W (2019) MiR-182-5p attenuates high-fat -diet-induced nonalcoholic steatohepatitis in mice. Ann Hepatol 18:116\u2013125. https:\/\/doi.org\/10.5604\/01.3001.0012.7902","journal-title":"Ann Hepatol"},{"key":"5624_CR38","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.3724\/abbs.2022130","volume":"54","author":"X Zhao","year":"2022","unstructured":"Zhao X, Xia Z, Wang Z, Zhou M, Qiu X, Wang C, Xu T, Fang Q, Ming Z, Dong H (2022) MiR-182-5p attenuates Schistosoma japonicum-induced hepatic fibrosis by targeting tristetraprolin. Acta Biochim Biophys Sin (Shanghai) 54:1421\u20131430. https:\/\/doi.org\/10.3724\/abbs.2022130","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"5624_CR39","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1093\/toxsci\/kfw246","volume":"156","author":"Y Jiang","year":"2017","unstructured":"Jiang Y, Chen J, Yue C, Zhang H, Tong J, Li J, Chen T (2017) The role of miR-182-5p in hepatocarcinogenesis of trichloroethylene in mice. Toxicol Sci 156:208\u2013216. https:\/\/doi.org\/10.1093\/toxsci\/kfw246","journal-title":"Toxicol Sci"},{"key":"5624_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24119239","author":"C Compagnoni","year":"2023","unstructured":"Compagnoni C, Capelli R, Zelli V, Corrente A, Vecchiotti D, Flati I, Di Vito Nolfi M, Angelucci A, Alesse E, Zazzeroni F, Tessitore A (2023) MiR-182-5p is upregulated in hepatic tissues from a diet-induced NAFLD\/NASH\/HCC C57BL\/6J mouse model and modulates Cyld and Foxo1 expression. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24119239","journal-title":"Int J Mol Sci"},{"key":"5624_CR41","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12931-025-03474-5","volume":"27","author":"JK Lee","year":"2026","unstructured":"Lee JK, Park JK, Nam JY, Kim HC (2026) Plasma extracellular vesicles-derived MicroRNAs as potential biomarkers in idiopathic pulmonary fibrosis. Respir Res 27:41. https:\/\/doi.org\/10.1186\/s12931-025-03474-5","journal-title":"Respir Res"},{"key":"5624_CR42","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1210\/clinem\/dgae876","volume":"110","author":"B Yu","year":"2025","unstructured":"Yu B, Wang Y, Jin J, Liu J, Huang Y, Wang Y, Zhu C, Li Y, Li B, Sun J, Li D, Fang S, Zhou H (2025) CD34\u2009+\u2009orbital fibroblasts contribute to the pathogenesis of thyroid eye disease via miR-182-5p. J Clin Endocrinol Metab 110:2631\u20132644. https:\/\/doi.org\/10.1210\/clinem\/dgae876","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05624-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-026-05624-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05624-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T09:15:21Z","timestamp":1787908521000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-026-05624-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":42,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["5624"],"URL":"https:\/\/doi.org\/10.1007\/s11010-026-05624-9","relation":{},"ISSN":["1573-4919"],"issn-type":[{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"23 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None of the authors have any conflicts of interest that might affect the content of this work.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Since our study involved live vertebrate animals (mice), it was conducted in strict accordance with the ARRIVE guidelines. This study was reviewed and approved by [Hainan University's Animal Ethics Committee] with the approval number: [HPIACUC2023023 and HPIACUC2026008], dated [July 18th, 2023 and Jan 20th, 2026, respectively]. We confirmed that all experimental methods have been carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","label":"Ethical approval and Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}]}}